-
Product Insights
Tieling Biomass Utilization Project
Tieling Biomass Utilization Project is a biopower project located in Liaoning, China. The project is owned and developed by Tieling Evergreen Environmental Energy Ltd. The project came online in 2020. Empower your strategies with our Tieling Biomass Utilization Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
Xinye Biomass Cogeneration Project
Xinye Biomass Cogeneration Project is a biopower project located in Henan, China. The project is owned and developed by Guangdong Evergreen Group Co Ltd. The project is currently under construction. Empower your strategies with our Xinye Biomass Cogeneration Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the...
-
Product Insights
Mahuva II Wind Farm
Mahuva II Wind Farm is an Onshore Wind project located in Gujarat, India. The project is owned and developed by Evergreen Power Mauritius Pvt Ltd; KP Energy Ltd. The project is currently under construction. Empower your strategies with our Mahuva II Wind Farm report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Shandong Tancheng Biomass Power Generation Project
Shandong Tancheng Biomass Power Generation Project is a biopower project located in Shandong, China. The project is owned and developed by Guangdong Evergreen Group Co Ltd. The project is currently under construction. Empower your strategies with our Shandong Tancheng Biomass Power Generation Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
Henan Yongcheng Biomass CHP Project
Henan Yongcheng Biomass CHP Project is a biopower project located in Henan, China. The project is owned by Guangdong Evergreen Group Co Ltd and was developed by Guangdong Chant Group Inc. The project came online in 2020. Empower your strategies with our Henan Yongcheng Biomass CHP Project report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – CHF-10067 in Idiopathic Pulmonary Fibrosis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.CHF-10067 in Idiopathic Pulmonary Fibrosis Drug Details:CHF-10067 is under development for the treatment of idiopathic pulmonary...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-001 in Idiopathic Interstitial Pneumonia (IIP)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-001 in Idiopathic Interstitial Pneumonia (IIP) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-001 in Idiopathic Interstitial Pneumonia (IIP)Drug Details:EG-001 is under development for...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-501 in Cognitive Impairment
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-501 in Cognitive Impairment report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Cognitive ImpairmentDrug Details:EG-501 is under development for the treatment of cognitive...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EG-501 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - EG-501 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.EG-501 in Systemic Lupus Erythematosus Drug Details:EG-501 is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – STMC-103H in Allergies
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - STMC-103H in Allergies report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.STMC-103H in Allergies Drug Details:STMC-103H is under development for the treatment and prevention of...